Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to determine the progression-free survival (PFS) of patients with metastatic malignant melanoma who have not received prior chemotherapy for metastatic disease when treated with IMC-1121B alone or in combination with dacarbazine.
Critère d'inclusion
- Metastatic Malignant Melanoma